A Search Service for Abbreviation / Long Form

■ Search Result - Abbreviation : rIL-2

Search Conditions:
Search Keyword : rIL-2
Search Method : Exact match.
Research Area:

Abbreviation: rIL-2
Appearance Frequency: 1267 time(s)
Long forms: 16

Display Settings:
[Entries Per Page]
 per page
Page Control
Page: of
Long Form No. Long Form Research Area Co-occurring Abbreviation PubMed/MEDLINE Info. (Year, Title)
recombinant interleukin-2
(972 times)
(395 times)
LAK (219 times)
NK (167 times)
PBMC (56 times)
1984 Human recombinant interleukin-2 partly reconstitutes deficient in-vitro immune responses of lymphocytes from patients with AIDS.
recombinant IL-2
(165 times)
Allergy and Immunology
(91 times)
IL-2 (75 times)
IL-2R (28 times)
LAK (21 times)
1984 Detection and functional studies of p60-65 (Tac antigen) on activated human B cells.
recombinant human interleukin-2
(99 times)
Allergy and Immunology
(47 times)
NK (14 times)
LAK (11 times)
rIFN-gamma (6 times)
1984 Systemic administration of recombinant human interleukin-2 in mice.
recombinant human IL-2
(16 times)
Allergy and Immunology
(7 times)
IL-2 (8 times)
NK (4 times)
LAK (3 times)
1985 Use of Millipore diffusion chambers to assay in vivo IL-2 activity.
recombinant cytokines, interleukin-2
(4 times)
(1 time)
anti-Id (1 time)
BHV-1 (1 time)
BRMs (1 time)
1987 In vivo anti-tumor activity of combinations of interferon alpha and interleukin-2 in a murine model. Correlation of efficacy with the induction of cytotoxic cells resembling natural killer cells.
interleukin-2 receptor
(1 time)
Acquired Immunodeficiency Syndrome
(1 time)
HIV-1 (1 time)
IFN-gamma (1 time)
1990 Interferon-gamma marks activated T lymphocytes in AIDS patients.
(1 time)
(1 time)
RCC (1 time)
rIFN-alpha (1 time)
1999 Subcutaneous administration of interleukin-2 and interferon-alpha 2b in advanced renal cell carcinoma: long-term results.
received combined Interleukin-2
(1 time)
Allergy and Immunology
(1 time)
auto-SCT (1 time)
IFN-alpha (1 time)
ML (1 time)
2010 A randomized controlled multicenter study comparing recombinant interleukin 2 (rIL-2) in conjunction with recombinant interferon alpha (IFN-alpha) versus no immunotherapy for patients with malignant lymphoma postautologous stem cell transplantation.
recombinant DNA-produced human IL-2
(1 time)
Allergy and Immunology
(1 time)
Con A (1 time)
CYP (1 time)
NMU (1 time)
1987 Signals provided in vivo by human rIL-2 and Con A can switch hapten-specific tolerance from unresponsiveness to responsiveness in the South African clawed toad.
10  recombinant Escherichia coli-derived IL-2
(1 time)
(1 time)
IL-2 (1 time)
1986 Studies of structure-activity relationships of human interleukin-2.
11  recombinant human interleukin-2 protein
(1 time)
(1 time)
--- 2005 Suppression of morphine withdrawal syndrome by interleukin-2 and its gene.
12  recombinant interleukin 2 from Escherichia coli
(1 time)
Allergy and Immunology
(1 time)
--- 1988 Recombinant human interleukin 2 (rIL-2) enhancement of antibody production by human-human hybridomas.
13  recombinant Interleukin-2 treatment
(1 time)
(1 time)
PS (1 time)
RCC (1 time)
1992 Prognostic factors for survival in patients with advanced renal cell carcinoma treated with recombinant interleukin-2.
14  recombinant mouse IL-2
(1 time)
(1 time)
Con A (1 time)
EM (1 time)
IL-2R (1 time)
1996 Detection and spatial distribution of IL-2 receptors on mouse T-lymphocytes by immunogold-labeled ligands.
15  response modifier interleukin-2
(1 time)
Antineoplastic Agents
(1 time)
AIC (1 time)
AUC (1 time)
1990 Alteration of dacarbazine pharmacokinetics after interleukin-2 administration in melanoma patients.
16  responsiveness to interleukin 2
(1 time)
Allergy and Immunology
(1 time)
IL-2R, p55 (1 time)
mAb (1 time)
PBL (1 time)
1991 Stimulation of human T cells via anti-T cell receptor monoclonal antibody BMA031: distinct cellular events involving interleukin-2 receptor and lymphocyte function antigen 1.